Senate LDA lobbying filing

ELI LILLY AND COMPANY

Registrant: THE SIMMONS & RUSSELL GROUP, LLC Year: 2024 Period: Third Quarter Type: Q3

View on lda.senate.gov ↗

Reported income

$60.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

Robust Infrastructure and Access0208085JCYmatched: “Infrastructure|Access”matched 2+ title words
Issues related to the pharmaceutical industry including healthcare policy, drug pricing, drug value, insulin, and the…

Lobbying activities2

PharmacyPHA
Issues related to the pharmaceutical industry including healthcare policy, drug pricing, drug value, insulin, and the 340B Program. Monitoring implementation of the Inflation Reduction Act of 2022, H.R.5376, P.L.117-169. Monitoring implementation of the Infrastructure Investment and Jobs Act, H.R.3684, P.L.117-58. Issues related to obesity reduction. Issues related to Alzheimers coverage and access. Issues related to PBM reform.
Taxation/Internal Revenue CodeTAX
Issues related to tax legislation; Tax Relief for American Families and Workers Act of 2024, H.R.7024.

Lobbyists2

KYLE SIMMONS
ROBERT RUSSELL

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.